Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Kebilidi (eladocagene exuparvovec-tneq) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Jynarque (tolvaptan) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | JAK2, MPL, and CALR Testing for Myeloproliferative Neoplasms | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Itvisma (onasemnogene abeparvovec-brve) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Isturisa (osilodrostat) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Isotretinoin Products | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Isolated Small Bowel Transplant | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Islet Transplantation for Chronic Pancreatitis and Donislecel-jujn for Type 1 Diabetes | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Irreversible Electroporation of Tumors Located in the Liver, Pancreas, Kidney, Lung, or Prostate | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Invasive Prenatal (Fetal) Diagnostic Testing | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intravitreal Angiogenesis Inhibitors | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intravenous Nutrient Therapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intravenous Iron Replacement Therapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric Disorders | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intraoperative Radiotherapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intraoperative Neurophysiologic Monitoring | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intraocular Radiotherapy for Age-Related Macular Degeneration | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intradialytic Parenteral Nutrition | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intracoronary Drug Delivery Balloon Procedures | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intracellular Micronutrient Analysis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intracavitary Balloon Catheter Brain Brachytherapy for Malignant Gliomas or Metastasis to the Brain | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intra-articular Hyaluronan Injections for Osteoarthritis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Interventions for Progressive Scoliosis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Interstitial Lung Disease | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Interspinous Fixation (Fusion) Devices | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Interspinous and Interlaminar Stabilization/Distraction Devices (Spacers) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Interleukin-5 Antagonist Monoclonal Antibodies | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Interleukin-1 Inhibitors (Arcalyst, Ilaris, Kineret) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Interim PET Scanning in Oncology to Detect Early Response During Treatment | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Interferential Current Stimulation | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intensity-Modulated Radiotherapy (IMRT): Prostate | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intensity-Modulated Radiotherapy (IMRT): Central Nervous System Tumors | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intensity-Modulated Radiotherapy (IMRT): Cancer of the Head and Neck or Thyroid | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intensity-Modulated Radiotherapy (IMRT): Breast and Lung | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intensity-Modulated Radiotherapy (IMRT): Abdomen, Pelvis and Chest | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Insulins (Non-Long Acting Products) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Injectable Oncology | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Inhaled Nitric Oxide | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Inhaled Antibiotics for Cystic Fibrosis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Ingestible pH and Pressure Capsule | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Influenza Vaccine | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | In Vitro Chemoresistance and Chemosensitivity Assays | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Implantation of Intrastromal Corneal Ring Segments | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Implantable Peripheral Nerve Stimulation for Chronic Pain Conditions | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Implantable Infusion Pump | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Implantable Cardioverter Defibrillator | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Implantable Bone-Conduction and Bone-Anchored Hearing Aids | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Impavido (miltefosine) | New policy |